Patents by Inventor Xiaobei Wang

Xiaobei Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polyethylene Glycol-Conjugated Glucocorticoid Prodrugs and Compositions and Methods Thereof
    Publication number: 20240000800
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Application
    Filed: February 21, 2023
    Publication date: January 4, 2024
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
    Patent number: 11583541
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Grant
    Filed: March 1, 2021
    Date of Patent: February 21, 2023
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • Polyethylene Glycol-Conjugated Glucocorticoid Prodrugs and Compositions and Methods Thereof
    Publication number: 20210252018
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Application
    Filed: March 1, 2021
    Publication date: August 19, 2021
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • Method, apparatus and system for generating collocation renderings
    Patent number: 11055770
    Abstract: A method for generating a collocation rendering including acquiring a list of to-be-collocated transaction objects and acquiring a preset collocation template; and generating image information of a collocation rendering of the to-be-collocated transaction objects according to collocation attribute information of the to-be-collocated transaction objects and the preset collocation template. By means of the above technical solution, a plurality of transaction objects are automatically combined and collocated into a scene, thus allowing a user to appreciate a rendering effect of collocating the plurality of transaction objects together.
    Type: Grant
    Filed: November 30, 2018
    Date of Patent: July 6, 2021
    Assignee: Alibaba Group Holding Limited
    Inventors: Xiaobei Wang, Tao Fang, Ruhua Huang
  • Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
    Patent number: 10933071
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Grant
    Filed: November 25, 2019
    Date of Patent: March 2, 2021
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • Polyethylene Glycol-Conjugated Glucocorticoid Prodrugs and Compositions and Methods Thereof
    Publication number: 20200085842
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Application
    Filed: November 25, 2019
    Publication date: March 19, 2020
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • Polyethylene glycol-conjugated glucocorticoid prodrugs and compositions and methods thereof
    Patent number: 10485809
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Grant
    Filed: November 12, 2016
    Date of Patent: November 26, 2019
    Assignee: Board of Regents of the University of Nebraska
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang
  • METHOD, APPARATUS AND SYSTEM FOR GENERATING COLLOCATION RENDERINGS
    Publication number: 20190095985
    Abstract: A method for generating a collocation rendering including acquiring a list of to-be-collocated transaction objects and acquiring a preset collocation template; and generating image information of a collocation rendering of the to-be-collocated transaction objects according to collocation attribute information of the to-be-collocated transaction objects and the preset collocation template. By means of the above technical solution, a plurality of transaction objects are automatically combined and collocated into a scene, thus allowing a user to appreciate a rendering effect of collocating the plurality of transaction objects together.
    Type: Application
    Filed: November 30, 2018
    Publication date: March 28, 2019
    Inventors: Xiaobei Wang, Tao Fang, Ruhua Huang
  • Polyethylene Glycol-Conjugated Glucocorticoid Prodrugs and Compositions and Methods Thereof
    Publication number: 20180318318
    Abstract: Polyethylene glycol (PEG)-conjugated glucocorticoid prodrugs, methods of preparation, and use for the treatment of diseases and disorders are disclosed. In particular, PEG-conjugated dexamethasone compounds and methods of using them for treating inflammatory and autoimmune diseases, including but not limited to lupus, are disclosed.
    Type: Application
    Filed: November 12, 2016
    Publication date: November 8, 2018
    Applicant: Board of Regents of the University of Nebraska
    Inventors: Dong Wang, Fang Yuan, Zhenshan Jia, Xiaobei Wang